If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes
Get Live Data
0.25    0.00 (0.00%)
Bid:
0.20
Ask:
0.30
Spread: 0.10 (50.00%)
Market Cap: £1.31m
EXR Live PriceLast checked at - London Stock Exchange

Intraday Engage Xr Share Chart

Rule 8.3- EXPRO

27 Jun 2008 12:41

RNS Number : 7326X
UBS AG
27 June 2008
 



FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

 

1. KEY INFORMATION

Name of person dealing (Note 1)

UBS AG London Branch

Company dealt in

Expro International Group Plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ord 10p

Date of dealing

26 JUNE 2008

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number 

(%)

Number

(%)

(1) Relevant securities 

625,376

0.57%

0

0.00%

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

625,376

0.57%

0

0.00%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

(c) Rights to subscribe (Note 3)

 Class of relevant security:

Details

3. DEALINGS (Note 4)

 (a) Purchases and sales

 

Purchase/sale

Number of securities

Price per unit (Note 5)

SALE

4658

1610 PENCE

SALE

4655

1611

SALE

73059

1611

SALE

964

1611

SALE

48642

1611

SALE

4655

1611

PURCHASE

4655

1611

SALE

5000

1611

SALE

10521

1611

SALE

30000

1611

SALE

218

1611

PURCHASE

852

1611

SALE

5000

1611

SALE

782

1611

SALE

4218

1611

SALE

10000

1611

SALE

40000

1611

SALE

40000

1611

SALE

14000

1611

SALE

36000

1611

SALE

50000

1611

SALE

25000

1611

SALE

5900

1611

SALE

100000

1611

PURCHASE

850

1611

PURCHASE

150

1611

SALE

850

1611

SALE

150

1611

SALE

50000

1611

SALE

9700

1611

SALE

39300

1611

SALE

132492

1611

SALE

2500

1612

SALE

1467

1612

SALE

1467

1612

SALE

4652

1612

SALE

10998

1612

SALE

14000

1612

SALE

3030

1612

SALE

1000

1612

SALE

92491

1612

SALE

30000

1612

SALE

9479

1612

SALE

30000

1613

SALE

1576

1613

SALE

18424

1613

PURCHASE

4649

1613

SALE

4649

1613

SALE

32000

1613

SALE

4649

1613

SALE

13351

1613

SALE

1510

1613

PURCHASE

4646

1614

PURCHASE

4646

1614

SALE

4646

1614

SALE

2000

1614

PURCHASE

4643

1615

PURCHASE

4643

1615

PURCHASE

91

1617

PURCHASE

386

1617

PURCHASE

964

1620

PURCHASE

800

1620

SALE

2690

1620

SALE

3546

1620

SALE

964

1620

SALE

856

1620

SALE

800

1620

SALE

3546

1620

SALE

459

1620

SALE

459

1620

SALE

3546

1620

SALE

3546

1620

SALE

459

1620

SALE

1511

1620

SALE

3546

1620

SALE

3546

1620

SALE

3546

1620

SALE

459

1620

SALE

1542

1622

SALE

459

1625

SALE

5000

1625

SALE

964

1626

PURCHASE

1077

1628

SALE

209

1629

PURCHASE

584

1630

SALE

1843

1630

SALE

35

1630

SALE

177

1630

SALE

249

1630

PURCHASE

445

1630

PURCHASE

163

1631

SALE

618

1631

PURCHASE

69

1632

PURCHASE

920

1632

SALE

975

1632

SALE

362

1632

SALE

552

1632

SALE

137

1633

SALE

607

1633

PURCHASE

850

1633

SALE

850

1633

PURCHASE

100

1633

PURCHASE

186

1633

PURCHASE

200

1634

PURCHASE

821

1634

PURCHASE

361

1634

SALE

300

1634

TOTAL PURCHASES

37,751

TOTAL SALES

1,078,011

 

(b) Derivatives transactions (other than options)

Product name, e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5) 

(d) Other dealings (including new securities) (Note 4)

 Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

……………………………………………………………………

……………………………………………………………………

Is a Supplemental Form 8 attached? (Note 9) NO

 

Date of disclosure

27 JUNE 2008

Contact name

NIMISHA SACHDEV

Telephone number

020 7567 8762

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETUBSARWRRNUAR
Date   Source Headline
26th Apr 20067:02 amRNSDirectorate Change
28th Mar 20067:00 amRNSTrading Statement
13th Feb 20064:32 pmRNSDirector/PDMR Shareholding
13th Feb 20064:31 pmRNSDirector/PDMR Shareholding
13th Feb 20063:09 pmRNSAdditional Listing
13th Feb 20062:42 pmRNSBlocklisting Interim Review
12th Jan 20064:00 pmRNSInvestor Presentation
11th Jan 20068:08 amRNSPositive Forecast Update
13th Dec 20057:01 amRNSRe Contract
24th Nov 200512:06 pmRNSDividend Amendment
24th Nov 20057:02 amRNSInterim Results
15th Nov 20053:35 pmRNSSale of QuantX
15th Nov 20057:01 amRNSIFRS Restatements
7th Nov 200511:49 amRNSAdditional Listing
3rd Nov 20054:35 pmRNSHolding(s) in Company
2nd Nov 200511:00 amRNSNotice of Results
28th Sep 20057:01 amRNSTrading Statement
15th Sep 200510:28 amRNSBlocklisting Interim Review
19th Jul 20057:00 amRNSInvestor Visits
8th Jul 200511:25 amRNSInvestor Visit
6th Jul 20053:27 pmRNSAGM Statement
27th Jun 20052:24 pmRNSAnnual Report and Accounts
10th Jun 20058:51 amRNSDirector Shareholding
8th Jun 20059:43 amRNSDirector Shareholding
8th Jun 20059:42 amRNSDirector Shareholding
8th Jun 20059:35 amRNSDirector Shareholding
2nd Jun 200510:01 amRNSResult of Placing
2nd Jun 20057:02 amRNSCash Placing
2nd Jun 20057:02 amRNSFinal Results
23rd May 20059:07 amRNSNotice of Results
13th Apr 20057:00 amRNSAcquisition
24th Mar 20051:30 pmRNSCapital Reorganisation
22nd Mar 20057:01 amRNSTrading Statement
24th Feb 20053:34 pmRNSBlocklisting Interim Review
24th Feb 20051:09 pmRNSDirector Shareholding
23rd Feb 200511:35 amRNSEGM - Capital Reorganisation
18th Feb 20057:02 amRNSRe Contract
9th Feb 20052:00 pmRNSRe Contract
2nd Feb 20057:00 amRNSAcquisition
1st Feb 20055:56 pmRNSDirector Shareholding
28th Jan 20057:00 amRNSCapital Reorganisation
10th Jan 20055:05 pmRNSDirector Shareholding
10th Jan 20055:03 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.